Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-9 of 9 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2018Advances in lipid-lowering therapy through gene-silencing technologiesNordestgaard, B.; Nicholls, S.; Langsted, A.; Ray, K.; Tybjærg-Hansen, A.
2018Rationale and design of a trial to personalize risk assessment in familial coronary artery diseaseMarwick, T.; Whitmore, K.; Nicholls, S.; Stanton, T.; Mitchell, G.; Tonkin, A.; Blizzard, C.; Neil, A.; Jones, C.; Watts, G.
2018Association of lipoprotein(a) with risk of recurrent ischemic events following acute coronary syndrome: analysis of the dal-outcomes randomized clinical trialSchwartz, G.; Ballantyne, C.; Barter, P.; Kallend, D.; Leiter, L.; Leitersdorf, E.; McMurray, J.; Nicholls, S.; Olsson, A.; Shah, P.; Tardif, J.-C.; Kittelson, J.
2018Eradicating the burden of atherosclerotic cardiovascular disease by lowering apolipoprotein B lipoproteins earlier in lifeRobinson, J.; Williams, K.; Gidding, S.; Borén, J.; Tabas, I.; Fisher, E.; Packard, C.; Pencina, M.; Fayad, Z.; Mani, V.; Rye, K.; Nordestgaard, B.; Tybjærg-Hansen, A.; Douglas, P.; Nicholls, S.; Pagidipati, N.; Sniderman, A.
2018Effect of evolocumab on coronary plaque compositionNicholls, S.; Puri, R.; Anderson, T.; Ballantyne, C.; Cho, L.; Kastelein, J.; Koenig, W.; Somaratne, R.; Kassahun, H.; Yang, J.; Wasserman, S.; Honda, S.; Shishikura, D.; Scherer, D.; Borgman, M.; Brennan, D.; Wolski, K.; Nissen, S.
2018Translating evidence of HDL and plaque regressionDi Bartolo, B.; Psaltis, P.; Bursill, C.; Nicholls, S.
2018Lipid lowering in acute coronary syndrome: is treatment early enough?Nicholls, S.; Psaltis, P.
2018Extent of coronary atherosclerosis and arterial remodelling in women: the NHLBI-sponsored Women's Ischemia Syndrome EvaluationNicholls, S.; Tuzcu, E.; Wolski, K.; Johnson, B.; Sopko, G.; Sharaf, B.; Pepine, C.; Nissen, S.; Merz, C.
2018Myeloperoxidase modification of high-density lipoprotein suppresses human endothelial cell proliferation and migration via inhibition of ERK1/2 and Akt activationChen, X.; Duong, M.; Nicholls, S.; Bursill, C.